1. A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy. Issue 2 (28th February 2016) Authors: Chao, Tzu-I; Tai, Wei-Tien; Hung, Man-Hsin; Tsai, Ming-Hsien; Chen, Min-Hsuan; Chang, Mao-Ju; Shiau, Chung-Wai; Chen, Kuen-Feng Journal: Cancer letters Issue: Volume 371:Issue 2(2016) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atopic dermatitis and risk of ischemic stroke: A nationwide population-based study. (March 2014) Authors: Su, Vincent Yi-Fong; Chen, Tzeng-Ji; Yeh, Chiu-Mei; Chou, Kun-Ta; Hung, Man-Hsin; Chu, Szu-Ying; Su, Kang-Cheng; Chang, Yu-Sheng; Lin, Ya-Hsuan; Liu, Chia-Jen Journal: Annals of medicine Issue: Volume 46:Number 2(2014) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease. Issue 5 (February 2016) Authors: Su, Vincent Yi-Fong; Chang, Yu-Sheng; Hu, Yu-Wen; Hung, Man-Hsin; Ou, Shuo-Ming; Lee, Fa-Yauh; Chou, Kun-Ta; Yang, Kuang-Yao; Perng, Diahn-Warng; Chen, Tzeng-Ji; Liu, Chia-Jen Editors: Mauro., Feola Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: e2427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease. Issue 5 (February 2016) Authors: Su, Vincent Yi-Fong; Chang, Yu-Sheng; Hu, Yu-Wen; Hung, Man-Hsin; Ou, Shuo-Ming; Lee, Fa-Yauh; Chou, Kun-Ta; Yang, Kuang-Yao; Perng, Diahn-Warng; Chen, Tzeng-Ji; Liu, Chia-Jen Other Names: Mauro. Feola section editor. Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112 (October) (2017) 81–89]. (July 2018) Authors: Hsieh, Feng-Shu; Hung, Man-Hsin; Wang, Cheng-Yi; Chen, Yen-Lin; Hsiao, Yung-Jen; Tsai, Ming-Hsien; Li, Jia-Rong; Chen, Li-Ju; Shih, Chih-Ting; Chao, Tzu-I; Chen, Kuen-Feng Journal: Lung cancer Issue: Volume 121(2018) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112, (October) (2017) 81–89]. (May 2018) Authors: Hsieh, Feng-Shu; Hung, Man-Hsin; Wang, Cheng-Yi; Chen, Yen-Lin; Hsiao, Yung-Jen; Tsai, Ming-Hsien; Li, Jia-Rong; Chen, Li-Ju; Shih, Chih-Ting; Chao, Tzu-I; Chen, Kuen-Feng Journal: Lung cancer Issue: Volume 119(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation. (October 2017) Authors: Hsieh, Feng-Shu; Hung, Man-Hsin; Wang, Cheng-Yi; Chen, Yen-Lin; Hsiao, Yung-Jen; Tsai, Ming-Hsien; Li, Jia-Rong; Chen, Li-Ju; Shih, Chih-Ting; Chao, Tzu-I; Chen, Kuen-Feng Journal: Lung cancer Issue: Volume 112(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B. Issue 8 (3rd August 2015) Authors: Wu, Chia-Yun; Hsiao, Liang-Tsai; Chiou, Tzeon-Jye; Gau, Jyh-Pyng; Liu, Jin-Hwang; Yu, Yuan-Bin; Wu, Yi-Tsui; Liu, Chia-Jen; Huang, Yu-Chung; Hung, Man-Hsin; Chen, Po-Min; Huang, Yi-Hsiang; Tzeng, Cheng-Hwai Journal: Leukemia & lymphoma Issue: Volume 56:Issue 8(2015:Aug.) Page Start: 2357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib. (3rd October 2017) Authors: Ko, Po-Shen; Yu, Yuan-Bin; Liu, Yao-Chung; Wu, Yi-Tsui; Hung, Man-Hsin; Gau, Jyh-Pyng; Liu, Chia-Jen; Hsiao, Liang-Tsai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chun-Yu; Liu, Jin-Hwang Journal: Current medical research and opinion Issue: Volume 33:Number 10(2017) Page Start: 1737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response. (October 2018) Authors: Huang, Chao-Yuan; Hsieh, Feng-Shu; Wang, Cheng-Yi; Chen, Li-Ju; Chang, Shih-Shin; Tsai, Ming-Hsien; Hung, Man-Hsin; Kuo, Chiung-Wen; Shih, Chi-Ting; Chao, Tzu-I; Chen, Kuen-Feng Journal: European journal of cancer Issue: Volume 102(2018) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗